This study demonstrates a federated learning approach for detecting brain tumours in MRI images, indicating strong privacy compliance and diagnostic potential.
BACKGROUND Artificial intelligence (AI) integration in medical diagnostics has shown promising results, particularly with deep learning (DL) models applied to medical imaging. However, centralized training methods require transferring sensitive patient data, posing significant privacy and regulatory concerns. OBJECTIVE This study proposes a federated learning (FL) framework using convolutional neural networks (CNNs) to detect brain tumours in MRI images in a privacy-preserving manner. The goal is to maintain diagnostic accuracy while ensuring data remains local to institutional nodes, in compliance with ethical and legal standards such as HIPAA and GDPR. METHODS MRI data from the publicly available Brain MRI Images for Brain Tumour Detection dataset was preprocessed (grayscale conversion, resizing to 64×64 pixels, normalization) and distributed across five simulated clients using the Flower FL framework within Google Colab. Each client trained a lightweight CNN locally; model parameters were aggregated using the FedAvg algorithm over five communication rounds. Performance was assessed using AUC, accuracy, precision, recall, F1-score, confusion matrices, and ROC curves. RESULTS The federated CNN achieved an AUC of 0.71 and an accuracy of 65%, with a training loss reduction from 0.52 to 0.31. Although performance was slightly lower than a centralized counterpart (AUC 0.76), the federated model effectively balanced privacy and diagnostic performance. Visual analysis confirmed meaningful differences in intensity features across classes. Data and training were retained locally, ensuring compliance with privacy protocols. CONCLUSIONS The proposed FL framework demonstrates the feasibility of decentralized, privacy-preserving deep learning for medical imaging. While the current study simulates idealized client conditions, future work will incorporate real-world heterogeneity, client dropout, and explainability tools like Grad-CAM to enhance clinical applicability and interpretability.
No takes yet. Share an insight, caveat, or question.
Nabeel Al-Milli (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: